Aurdan Capital Management LLC Makes New $9.78 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Aurdan Capital Management LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 19,333 shares of the healthcare conglomerate's stock, valued at approximately $9,780,000. UnitedHealth Group comprises about 3.8% of Aurdan Capital Management LLC's investment portfolio, making the stock its 6th largest position.

Several other hedge funds have also recently modified their holdings of the stock. Vermillion Wealth Management Inc. acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $90,000. AlphaCore Capital LLC raised its holdings in UnitedHealth Group by 6.8% in the 4th quarter. AlphaCore Capital LLC now owns 647 shares of the healthcare conglomerate's stock valued at $327,000 after acquiring an additional 41 shares during the last quarter. Mackenzie Financial Corp raised its holdings in UnitedHealth Group by 3.2% in the 4th quarter. Mackenzie Financial Corp now owns 695,945 shares of the healthcare conglomerate's stock valued at $352,051,000 after acquiring an additional 21,373 shares during the last quarter. Forum Financial Management LP increased its holdings in shares of UnitedHealth Group by 25.2% during the 4th quarter. Forum Financial Management LP now owns 8,480 shares of the healthcare conglomerate's stock worth $4,290,000 after buying an additional 1,709 shares during the last quarter. Finally, Baer Investment Advisory LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $2,056,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. TD Securities restated a "hold" rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and lowered their price objective for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. TD Cowen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a research report on Monday, May 19th. KeyCorp lowered their price objective on shares of UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Finally, Wolfe Research lowered their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $441.87.

UnitedHealth Group Stock Down 0.6%

Shares of UNH traded down $1.84 during midday trading on Thursday, reaching $296.27. The stock had a trading volume of 7,730,543 shares, compared to its average volume of 6,721,749. The company's fifty day simple moving average is $439.50 and its two-hundred day simple moving average is $498.65. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $268.76 billion, a price-to-earnings ratio of 19.11, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm posted $6.91 earnings per share. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Activity

In related news, Director John H. Noseworthy purchased 300 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the transaction, the director now owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy Patrick Flynn bought 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock valued at $31,607,768 over the last quarter. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.